Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Associate Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado

Topics of Professional Interest:
  • Antiretroviral Clinical Pharmacology
  • 2003 to 2006 - Antiretroviral Clinical Pharmacology Fellowship; University of Colorado Denver, Denver, Colorado
  • 2001 to 2002 - Pharmacy Practice Residency; University of California San Diego Medical Center, San Diego, California
  • 1997 to 2001 - Doctor of Pharmacy University of North Carolina Chapel Hill, Chapel Hill, North Carolina
Selected Publications:
    1. AASLD/IDSA HCV Guidance Panel. Hepatitis C Guidance: AASLD-IDSA Recommendations for Testing, Managing, and Treating Adults Infected with Hepatitis C Virus. Hepatology EPub 2015 Jun 25.
    2. Rower JE, Meissner EG, Jimmerson LC, Osinusi A, Sims Z, Petersen T, Bushman LR, Wolfe P, McHutchison JG, Kottilil S, Kiser JJ*. Serum and cellular ribavirin pharmacokinetic and concentration effect analysis in HCV patients receiving sofosbuvir plus ribavirin. J Antimicrob Chemother. EPub 2015 May 1.
    3. Wu LS, Rower JE, Burton JR Jr, Anderson PL, Hammond KP, Baouchi-Mokrane F, Everson GT, Urban TJ, D'Argenio DZ, Kiser JJ*. Population pharmaockinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother 2015;59(4):2179-88.
    4. Jimmerson LC, Ray ML, Bushman LR, Anderson PL, Klein B, Rower JE, Zheng J-H, Kiser JJ*. Determination of Intracellular Ribavirin Mono-, Di-, and Triphosphate Concentrations by Solid Phase Extraction and HPLC-MS-MS Detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;978-979:163-72.
    5. Moorehead KJ, Burton JR, Jr., Everson GT, J-H Zheng, Kerr BJ, Bushman LR, Wang M, Ju C, Nydam T, Kiser JJ*. Intrahepatic Antiviral Quantification in a Patient Undergoing Orthotopic Cadaveric Liver Transplantation. J Antimicrob Chemother. 2015;70(1):315-7.
    6. Jimmerson LC, Zheng J-H, Bushman LR, MacBrayne CE, Anderson PL, Kiser JJ*. Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry. J Chrom B 2014;944:18-24.
    7. Hammond KP, Nielsen C, Linnebur SA, Langness JA, Ray G, Maroni P, Kiser JJ*. Priapism Induced by Boceprevir-CYP3A4 inhibition and Alpha-Adrenergic Blockade. Clinical Infectious Diseases 2014;58(1):e35-8.
    8. Hammond KP, Wolfe P, Burton JR, Predhomme JA, Ellis CM, Ray ML, Bushman LR, Kiser JJ*. Pharmacokinetic Interaction between Boceprevir and Etravirine in HIV/HCV Seronegative Volunteers. JAIDS 2013;62(1):67-73. 
    9. Kiser JJ*, Burton JR, Everson GT.  Drug interactions in viral hepatitis.  Nature Reviews Gastroenterology & Hepatology 2013;10(10):596-606.
    10. Kiser JJ*, Flexner CW.  Direct Acting Antiviral Agents for Hepatitis C Virus Infection.  Annual Reviews in Pharmacology and Toxicology 2013;53:427-49.
    11. Kiser JJ*, Burton JR, Anderson PL, Everson GT.  Review and Management of Drug Interactions with Boceprevir and Telaprevir.  Hepatology 2012;55(5):1620-8.